Aztreonam Lysine Inhalation Solution in Cystic Fibrosis

Patients with cystic fibrosis (CF) develop pulmonary disease secondary to airway infection and dysregulated inflammation. Therapeutic innovations such as nebulized antimicrobial therapy targeting specific pathogens have resulted in improvements in quality of life and life expectancy. Aztreonam lysin...

Descripción completa

Detalles Bibliográficos
Autores principales: Elson, Elizabeth Claire, Mermis, Joel, Polineni, Deepika, Oermann, Christopher M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463232/
https://www.ncbi.nlm.nih.gov/pubmed/31019373
http://dx.doi.org/10.1177/1179548419842822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463232/
https://www.ncbi.nlm.nih.gov/pubmed/31019373
http://dx.doi.org/10.1177/1179548419842822

Ejemplares similares